Eleva’s CEO says CHO cell line alternatives could become common as large molecule drugs become complex and harder to produce ...

Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...

Expressing recombinant proteins is one of the most challenging, but at the same time most important tasks in the life sciences. Irrespective of the specific protein and the downstream applications, ...

Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its ...

The concept of a ‘plasmid’ was first introduced by Joshua Lederberg in 1952. Since that time, it has become widely recognized as a circular DNA able to viably function as a carrier for introducing a ...

After spending half a decade (and $150 million in funding) developing recombinant proteins made via precision fermentation, Remilk announced last week the launch of what it’s calling New ...

Recent developments in protein engineering technologies, such as cell-free methods, have brought the field into a golden era of innovation, creating new opportunities and ingenious products that can ...

Amy Sheng (left) is Head of the CRO Program at Sino Biological US Inc. (PA, USA), and has expertise in cell, molecular biology, immunology and biochemistry. In this interview, Amy discusses the ...

"If you can unlock triple digit titers this is the real game that's needed to achieve competitive pricing and profitability" ...